The three-dimensional structure of bovine lens leucine aminopeptidase (EC 3.4.11.1) complexed with bestatin, a slow-binding inhibitor, has been solved to 3.0-A resolution by the multiple isomorphous replacement method with phase combination and density modification. In addition, the structure of the isomorphous native enzyme has been refrmed at 2.7-A resolution, and the current crystallographic R factor is 0.169 for a model that includes the two zinc ions and all 487 amino acid residues comprising the asymmetric unit. The enzyme is physiologically active as a hexamer, which has 32 symmetry and is triangular in shape with a triangle edge length of 115 A and maximal thickness of 90 A. The Leucine aminopeptidases (LAPs; EC 3.4.11.1) are widely distributed cytosolic exopeptidases that catalyze the hydrolysis ofamino acids from the N terminus ofpolypeptide chains (1, 2). As their name implies, the LAPs cleave leucyl substrates, although substantial rates of enzymatic cleavage are seen with most amino-terminal amino acids. Bovine lens LAP is a hexameric enzyme of molecular weight 324,000, which consists of six identical subunits (3) of molecular weight 54,000 and 12 zinc ions (4). The amino acid sequence of the protein has been determined by both protein (5) and DNA (B.
The aminopeptidases form a group of exopeptidases that catalyze removal of amino acids from the N terminus of a protein. These enzymes are ubiquitous in nature and are of critical biological and medical importance because of their key role in protein degradation and in the metabolism of biologically active peptides. Whereas the mechanism of action and the three-dimensional structures of carboxypeptidases and endopeptidases are known in significant detail, our understanding of the aminopeptidases is much less well developed.
Leucine aminopeptidases (LAPs; EC 3.4.11.1) are widely distributed cytosolic exopeptidases that catalyze the hydrolysis ofamino acids from the N terminus ofpolypeptide chains (1, 2) . As their name implies, the LAPs cleave leucyl substrates, although substantial rates of enzymatic cleavage are seen with most amino-terminal amino acids. Bovine lens LAP is a hexameric enzyme of molecular weight 324,000, which consists of six identical subunits (3) of molecular weight 54,000 and 12 zinc ions (4) . The amino acid sequence of the protein has been determined by both protein (5) and DNA (B.
Waliner and A.T., unpublished data) sequencing methods. In addition, a potent, slow-binding inhibitor of LAP, bestatin or [(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]leucine, was isolated from culture filtrates of Streptomyces olivoreticuli (6) and was shown to have a Ki = 2 x 10-8 M for bovine lens LAP (7) .
Although there is considerable interest in LAP and in other aminopeptidases, no structural data are available for any aminopeptidase at high resolution. Two electron microscopic studies of bovine lens LAP have shown that the enzyme is a hexamer with 32 symmetry (8, 9) . Previous crystallographic studies have been limited to crystallization of bovine lens LAP (10), hog kidney LAP (11) , and Escherichia coli methionine aminopeptidase (12) and a description of an electrondensity map of bovine lens LAP determined by single isomorphous replacement and solvent flattening at 5-A resolution (13) .
We have solved the three-dimensional structure of the bestatin-inhibited enzyme by using the multiple isomorphous replacement (MIR) method at 3.0-A resolution with phase combination and density modification and have refined the structure of the isomorphous native enzyme at 2.7-A resolution. The active site has been identified and the environments of the two zinc ions have been characterized. Here, we report the general structural features of the enzyme; its secondary, tertiary, and quaternary structures; and the structure of the active site. § A detailed analysis of the mechanism of inhibition of the enzyme by bestatin and the results of refinement of both the native and bestatin-inhibited enzymes at high resolution will be published elsewhere.
MATERIALS AND METHODS
Purification and Crystallization. LAP from bovine lens was purified according to a modification of the method of Carpenter and coworkers (14) Structure Determination. The three-dimensional structure determination was carried out by three ofus (S.K.B., P.R.D., and W.N.L.). Heavy-atom derivatives of the inhibited enzyme were prepared by soaking crystals after equilibration of the heavy-atom solutions and the crystals by vapor diffusion (see Table 1 for details ofthe soaking conditions; the inhibited enzyme was chosen for the MIR study in the hopes of minimizing interactions between the active-site metals and heavy-atom reagents).
Diffraction data for the native enzyme were collected at the Resource for Crystallography located in the laboratory of N. h. Xuong (University of California, San Diego), where two multiwire proportional chambers (15) were used. Diffraction data for the bestatin-inhibited enzyme and six heavyatom derivatives were measured to 3.0-A resolution using a Xentronics-type area detector (16) with the Harvard datacollection software (17) . Small crystals and the moderately large unit cell required the use of double Franks mirrors (18, 19) . Reduction to intensities was performed using the BUDDHA package (17) and reduction to structure-factor amplitudes and local scaling was performed using the algorithm of Fox and Holmes (20) . Table 2 gives the statistics for data collection for the native enzyme, the enzyme-inhibitor complex, and its heavy-atom derivatives.
Isomorphous difference Patterson syntheses revealed a common, major heavy-atom binding site in the two mercurial derivatives, and the atomic position was refined by the method of Terwilliger and Eisenberg (21) . Despite repeated measurement attempts, anomalous scattering from mercury and uranium heavy atoms was not detected by either of the two Xentronics-type area detectors available in our laboratory and supplied by Siemens Analytical X-ray. However, anomalous scattering from the ethylmercury phosphate derivative was successfully measured using the FAST detector in the laboratory of J. Pflugrath (Cold Spring Harbor Laboratory) (data not shown). Difference Fourier syntheses confirmed the location of the common, major mercury binding site and allowed identification of two independent minor mercury binding sites, one in each of the two mercury derivatives. In addition, these preliminary MIR phases allowed identification of heavy-atom binding sites in the diuranate-and iridium-soaked crystals. Further improvement in the accuracy of the phase data resulted from combining Wang's density modification method implemented by Wolfgang Kabsch (22, 23) with the Hendrickson-Lattman coefficients obtained from the MIR method (24) . After density modification, each of the derivatives was reexamined by difference Fourier synthesis to identify yet more minor heavy-atom binding sites (see Table 2 for the results of heavy-atom refinement). The final average figure-of-merit obtained from the MIR method at 3.0-A resolution was 0.65.
The initial electron-density maps showed some well-defined right-handed a-helices and (-strands, but the majority of the loop regions were uninterpretable. A discontinuous, unrefined polyalanine model consisting of 347 of a possible 487 amino acids was used for the first round of phase combination and density modification (25, 26) . Subsequent rounds of phase combination/density modification used refined, discontinuous models obtained from manual rebuilding and chain extension using the molecular graphics package FRODO (27, 28) with an Evans & Sutherland Picture System 390, and positional refinement using XPLOR (29) with a DECstation 3100. The amino acid sequence was aligned by identifying three cysteine residues from the refined positions of the three mercury binding sites. In all, eight rounds of phase combination/model building/partial structure refinement were required to reveal the locations ofall 487 amino acids and two zinc ions that comprise the asymmetric unit. This iterative process was carried out at 3.0-A resolution to give a final R factor of 0.248 and rootmean-square deviations of 0.016 A and 3.7°for bond lengths and angles, respectively. The active site showed additional electron density adjacent to the zinc ions that is consistent with the structure of the slow-binding inhibitor bestatin, but no attempt was made to establish the precise orientation of the bestatin at this resolution. Recently, x-ray diffraction data to 2.25-A resolution from bovine lens LAP complexed with bestatin were obtained at the National Synchrotron Light Source in collaboration with R. M. Sweet. Refinement of these data is proceeding and the structure of the bestatininhibited enzyme will be published elsewhere.
Refinement of the isomorphous native structure at 2.7-A resolution was carried out using the structure factors obtained with the Xuong-Hamlin area detector system. The entire model was examined using a series of unrefined delete maps that spanned the polypeptide chain, and minor corrections to side-chain and backbone positions were made. Further model building and positional and temperature-factor refinement reduced the R factor to 0.169, with root-mean- difference Fourier syntheses that are consistent with water molecules in the first shell of hydration. The connectivity of this final model was checked by phase combination/density modification using the HendricksonLattman coefficients obtained from the MIR method and a partial structure model consisting of 2217 of 3723 nonhydrogen atoms, which was prepared by deleting the two zinc ions and all the residues not found in either a-helices or ,-strands.
The resulting electron-density map reproduced the entire trace, with the exception of a surface loop region with poor electron density at positions 12-17, which was not well defined in any of the electron-density maps.
RESULTS AND DISCUSSION Molecular Structure. The 487 amino acids and two zinc ions comprising the monomer are folded into two a/83-type quasispherical globular domains to give a comma-like shape, with approximate maximal dimensions of 90 x 55 x 55 A3. Fig. 1A shows the molecule as a ribbon drawing and Fig. 1B illustrates a stereodrawing of the a-carbon backbone with the two zinc ions. The secondary structure composition of the monomer is 40%o a-helix and 19%o p-strand.
The N-terminal 150 residues fold to give a five-stranded ,p-sheet sandwiched between four a-helices. The N terminus itself occurs as the middle strand of the sheet, which has four parallel strands and one antiparallel strand. There is a long loop connecting an a-helix and the fifth 8-strand comprising the sheet. This loop contains the site between residues Arg-137 and Lys-138, where trypsin cleaves the hexameric enzyme but leaves the enzyme intact and biochemically active (33) . There is no evidence of proteolytic cleavage of this or any other peptide bond in the protein.
An a-helix runs from residue 151 to 170 and connects the N-terminal domain with the C-terminal domain. This region of the molecule is dominated by a central, eight-membered, saddle-shaped p-sheet, which is sandwiched between groups of a-helices and constitutes the hydrophobic core of the C-terminal domain. In addition, there is a smaller threestranded p sheet, which is located on the monomer surface and is involved in interaction with other members of the enzyme hexamer. The two zinc ions and the active site are entirely located within the C-terminal or catalytic domain. This finding is consistent with the results of photoaffinity labeling experiments, which localized the active site to the larger of the two trypsin-cleavage fragments (A.T., unpublished data).
Hexamer Structure. Fig. 2 A and B illustrate the a-carbon backbone of the LAP trimer and hexamer, respectively. The two crystallographic 32 hexamers found in the unit cell are centered at (2/3, 1/3, 1/4) and (1/3, 2/3, 3/4). When viewed down its threefold symmetry axis the hexamer is triangular in shape with a triangle edge length of 115 A. The maximum extent of the hexamer along the threefold axis is 90 A. The view of hexamer shown in Fig. 2B compares favorably with similar electron microscopic views (8, 9) . In addition, the lowresolution models based on the results of electron microscopy (8, 9) are also in good agreement with the distribution of protein within the hexamer. The catalytic domains are clustered around the threefold axis, and the upper and lower trimers are related to one another by a twofold rotation. The N-terminal domains extend outward from the catalytic domains and are located far from the center of the hexamer. It is remarkable that our model of the LAP hexamer does not agree with the results of Vasil'ev et al. not show electron-density features corresponding to the N-terminal domains.
Although LAP consists of only a single polypeptide chain and has no known cooperativity, the hexameric enzyme complex illustrated in Fig. 2B bears a striking resemblance to the gross features of the structure of the multimeric regulatory enzyme aspartate transcarbamoylase (ATCase; aspartate carbamoyltransferase, EC 2.1.3.2), which is being actively studied in one of our laboratories (34) . In LAP the catalytic domain is analogous to the catalytic or C chain of ATCase, and the LAP N-terminal domain is analogous to the regulatory or R chain of ATCase.
Active Site. The enzyme active site is illustrated in Fig. 3 , which shows the electron density of the active-site residues and the two zinc ions. The active site is located near the edge of the central eight-stranded P-sheet (see Fig. 1B The deleted residues are shown as stick figures and each a-carbon atom is labeled. The two zinc ions are shown as crosses and are labeled by their site number. The chicken-wire mesh represents the difference electron density contoured at 3o.
Biochemistry: Burley et al. magnesium, manganese, or cobalt ions affected both kcat and Km (14) , thereby suggesting that the metal ions influence each other directly or via the protein.
This arrangement of the zinc ions has not been previously observed in x-ray crystallographic studies of zinc-containing proteases. It is, however, somewhat analogous to the arrangement of the metal ions in myohemerythrin, in which the two iron atoms are separated by about 3.23 A and are partially coordinated by the carboxylate side chains of glutamate and aspartate residues (35) . Unlike myohemerythrin, metal binding by LAP does not involve any histidine side chains.
The active site also includes two positively charged amino acid side chains (Lys-250 and Arg-336). The side chain of Lys-250 is located closest to zinc site 1. Arg-336 is nearly equidistant from the two metal-ion sites. It is tempting to speculate that one or both of these side chains may influence catalysis. However, any comments regarding the enzyme mechanism must await refinement of high-resolution structures of suitable enzyme-ligand complexes.
